+33 (0)6 47 17 67 07 contact@nexialist.fr
  • 
  •  Contact
  • Français
  • English
Nexialist - votre partenaire pour la conformité des dispositifs médicaux
  • The company
    • Discover Nexialist
    • Our team of experts
    • Recruitment area
  • Your needs
  • Our solutions
    • AQUILA – NEW
    • Phaos
    • PYXIS
    • nex’inform
    • Our solutions
  • News & Uptades
    • MDCG
    • Artificial Intelligence
    • Clinical evaluation
    • Corporate
    • Digital health
    • Electrical devices
    • Innovation
    • PMS / PMCF
    • Process / Production
    • Quality
    • Regulation
    • Risk management
    • Software
    • Technical documentation
    • Unique Device Identification System (UDI System)
    • GLOSSARY
Select Page

MDCG 2021-8 : Clinical investigation application/notification documents – May 2021

27 May 2021 | MDCG

Theme Clinical investigations Target Audience Sponsors Products concerned MD Documents mentioned MDR (EU) 2017/745 MDCG 2021-1 Rev.1   This guide lists all the useful documentation for clinical investigation requests in accordance with the MDR (EU) 2017/745 and...

MDCG 2021-7 : Notice to manufacturers and authorised representatives on the impact of genetic variants on SARS-COV-2 in vitro diagnostic medical devices – May 2021

19 May 2021 | MDCG

Theme COVID-19 Tests Target Audience Manufacturers, Authorised representatives Products concerned IVD Documents mentioned IVDR (EU) 2017/746 MEDDEV 2.12-1   This document is intended for manufacturers and authorised representatives of in vitro diagnostic medical...

MDCG 2021-6 Rev.1 : Regulation (EU) 2017/745 – Questions & Answers regarding clinical investigation – April 2021

10 May 2021 | MDCG

Theme Clinical investigation Target Audience Sponsors (recital 49) Products concerned MD Documents mentioned MDR (EU) 2017/746 Chapter VI Directive 90/385/EEC Directive 93/42/EEC ISO 14155 :2020   Aimed primarily at sponsors of clinical investigations, MDCG...

MDCG 2021-5 Rev.1 : Guidance on standardisation for medical devices – April 2021

10 May 2021 | MDCG

Theme Harmonised standard, conformity assessment Target Audience Manufacturers, Subcontractors, Notified Bodies Products concerned MD and IVDMD Documents mentioned MDR (EU) 2017/745 IVDR (EU) 2017/746 Directive 90/385/EEC Directive 93/42/EEC Directive 98/79/EC...

MDCG 2021-4 Rev 1 : Application of transitional provisions for certification of class D in vitro diagnostic medical devices according to Regulation (EU) 2017/746 – April 2021

10 May 2021 | MDCG

Theme Transitional provisions – Conformity Assessment – EURL Target Audience Manufacturers, Notified Bodies Products concerned Class D IVD Documents mentioned IVDR (EU) 2017/746   This guide in the form of questions and answers provides indications on how...
« Older Entries

Search in the Website

All the topics

  • Clinical evaluation
  • Corporate
  • Digital health
  • Electrical devices
  • Innovation
  • MDCG
  • PMS / PMCF
  • Process / Production
  • Quality
  • Regulation
  • Risk management
  • Unique Device Identification System (UDI System)

#Tags

Animal origin Biocompatibility Borderline Classification Clinical trials Datas Homologation Labeling Matières premières Medical devices Mise sur le marché Placing on the market Qualification Retraitement Sterilization Usability

Archives

Contact us

Le Forum Bat B
515 Avenue de La Tramontane
13600 La Ciotat
FRANCE

+33 (0)4 42 01 60 29
Write us

Nexialist

Nexialist : Intelligence règlementaire et conformité des produits de santé

About us

Nexialist works with companies in the medical device sector, including in vitro diagnostic and advanced therapy devices. We provide assistance with any compliance, quality, and regulatory-related challenges as well as product development and commercialisation strategy.

Legal informations

  • Privacy policy
  • Legal notice
  • Sitemap

Nexialist’s universe

  • NEXIALIST
  • NEXINFORM

Follow us on…

© NEXIALIST - Réalisation : Nathalie Brunelli, Mirobolus 2019